valsartan has been researched along with Right Ventricular Dysfunction in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, G; Lu, J; Shen, C; Xiong, C; Yang, Y | 1 |
| Choudhary, G; Clements, RT; Fernandez-Nicolas, A; Kue, NR; Mallem, K; Mancini, TJ; McCullough, DJ; Morrison, AR; Vang, A | 1 |
| Bouma, BJ; Mulder, BJM; Pieper, PG; Roos-Hesselink, JW; Sieswerda, GT; van der Bom, T; van Dijk, APJ; van Dissel, AC; Vliegen, HW; Winter, MM; Zwinderman, AH | 1 |
| Andersen, A; Andersen, S; Axelsen, JB; Bogaard, HJ; de Man, FS; Hyldebrandt, JA; Nielsen-Kudsk, JE; Nyengaard, JR; Ringgaard, S | 1 |
| Bouma, BJ; Groenink, M; Mulder, BJ; Pieper, PG; Roos-Hesslink, JW; Sieswerda, GT; van der Bom, T; van Dijk, AP; Vliegen, HW; Winter, MM; Zwinderman, AH | 1 |
| Bouma, BJ; Groenink, M; Mulder, BJ; Pieper, PG; Roos-Hesselink, JW; Sieswerda, GT; van der Bom, T; van Dijk, AP; Vliegen, HW; Winter, MM; Zwinderman, AH | 1 |
3 trial(s) available for valsartan and Right Ventricular Dysfunction
| Article | Year |
|---|---|
Long-term clinical outcomes of valsartan in patients with a systemic right ventricle: Follow-up of a multicenter randomized controlled trial.
Topics: Adult; Antihypertensive Agents; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Retrospective Studies; Time Factors; Treatment Outcome; Valsartan; Ventricular Dysfunction, Right; Young Adult | 2019 |
Rationale and design of a trial on the effect of angiotensin II receptor blockers on the function of the systemic right ventricle.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Double-Blind Method; Female; Follow-Up Studies; Heart Atria; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; Stroke Volume; Tetrazoles; Tomography, X-Ray Computed; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Right; Ventricular Function, Right | 2010 |
Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Double-Blind Method; Exercise Tolerance; Female; Follow-Up Studies; Heart Defects, Congenital; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Multidetector Computed Tomography; Outcome Assessment, Health Care; Pilot Projects; Quality of Life; Stroke Volume; Tetrazoles; Transposition of Great Vessels; Valine; Valsartan; Ventricular Dysfunction, Right | 2013 |
3 other study(ies) available for valsartan and Right Ventricular Dysfunction
| Article | Year |
|---|---|
Sacubitril/Valsartan in the Treatment of Right Ventricular Dysfunction in Patients With Heart Failure With Reduced Ejection Fraction: A Real-world Study.
Topics: Aminobutyrates; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Stroke Volume; Valsartan; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right; Ventricular Function, Left | 2022 |
Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan.
Topics: Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arterial Pressure; Biphenyl Compounds; Disease Models, Animal; Drug Combinations; Female; Fibrosis; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Neprilysin; Protease Inhibitors; Pulmonary Artery; Rats, Sprague-Dawley; Tetrazoles; Valsartan; Vascular Remodeling; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Remodeling | 2019 |
Effects of combined angiotensin II receptor antagonism and neprilysin inhibition in experimental pulmonary hypertension and right ventricular failure.
Topics: Aminobutyrates; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Biphenyl Compounds; Disease Models, Animal; Drug Combinations; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Pulmonary Circulation; Rats; Tetrazoles; Valsartan; Vascular Remodeling; Ventricular Dysfunction, Right | 2019 |